GlassScriptPhysician profile
Michael Cresson
NPI 1144751934
$2,293.61
in general payments reported to CMS, 2019-2025
9 companies · $635 in 2025
The $635 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $538 · 2024: $1,120 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,293.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,707.36 | 2023-2025 | Ultreon, Optis, Xience Skypoint |
| Abiomed | $223.71 | 2024 | Impella |
| Shockwave Medical, INC | $162.16 | 2025 | |
| Medtronic, INC. | $97.16 | 2024 | Onyx Frontier |
| Biosense Webster, INC. | $21.95 | 2024 | Carto 3 |
| Janssen Pharmaceuticals, INC | $21.68 | 2024 | Xarelto |
| Genentech USA, INC. | $21.57 | 2024 | Polivy |
| Novartis Pharmaceuticals Corporation | $19.06 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.96 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cresson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.